Clover Health Investments, Corp.
CLOV
$4.60
$0.112.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 57.03% | 62.88% | 46.93% | 48.53% | 34.27% |
| Total Other Revenue | -30.72% | -7.83% | -70.79% | 98.91% | 22.55% |
| Total Revenue | 55.60% | 62.05% | 44.74% | 49.81% | 34.07% |
| Cost of Revenue | 56.13% | 66.83% | 70.13% | 69.54% | 52.20% |
| Gross Profit | 53.57% | 46.52% | -20.99% | -10.88% | -7.68% |
| SG&A Expenses | 13.34% | 20.05% | 7.03% | 7.71% | 9.88% |
| Depreciation & Amortization | 43.15% | 10.52% | 22.09% | 19.76% | 19.39% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.50% | 55.70% | 49.84% | 52.87% | 40.04% |
| Operating Income | 365.19% | 2,245.53% | -129.95% | -161.47% | -237.85% |
| Income Before Tax | 364.71% | 2,245.53% | -129.60% | -177.48% | -247.53% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 364.71% | 2,245.53% | -129.60% | -177.48% | -247.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 364.71% | 2,245.53% | -123.25% | -166.27% | -242.79% |
| EBIT | 365.19% | 2,245.53% | -129.95% | -161.47% | -237.85% |
| EBITDA | 381.01% | 3,546.66% | -131.70% | -166.82% | -227.22% |
| EPS Basic | 356.73% | 2,111.54% | -112.47% | -154.01% | -236.84% |
| Normalized Basic EPS | 356.92% | 2,143.75% | -118.32% | -149.58% | -232.65% |
| EPS Diluted | 340.38% | 2,023.08% | -112.47% | -154.01% | -298.10% |
| Normalized Diluted EPS | 346.92% | 2,143.75% | -118.32% | -149.58% | -235.42% |
| Average Basic Shares Outstanding | 2.97% | 5.06% | 5.16% | 4.60% | 4.42% |
| Average Diluted Shares Outstanding | 7.15% | 5.06% | 5.16% | 4.60% | 2.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |